Amban, Flordeliza S.

HRN: 23 11 82  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2023
CEFUROXIME 1.5GM (VIAL)
05/27/2023
06/03/2023
IV
1.5 G
Q8h
T/C Acute Appendicitis
Waiting Final Action 
05/27/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2023
06/03/2023
IV
500 Mg
Q8h
T/C Acute Appemdicitis
Waiting Final Action 
05/29/2023
CEFUROXIME 500MG (TAB)
05/29/2023
06/05/2023
ORAL
500 Mg
BID
S/P Appendectomy
Waiting Final Action 
05/29/2023
METRONIDAZOLE 500MG (TAB)
05/29/2023
06/05/2023
ORAL
500 Mg
Q8h
S/P Laparotomy, Appendectomy
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: